MedPath

Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module

Not Applicable
Completed
Conditions
Polypharmacy
Inappropriate Prescribing
Interventions
Other: Quality Circle Deprescribing Module
Registration Number
NCT03688542
Lead Sponsor
Anne Niquille
Brief Summary

Older people residing in nursing homes (NH) are frequently polymedicated and often prescribed potentially inappropriate medications. Deprescribing has been proposed as a way to reduce the number of drugs they receive and their exposure to harmful treatments.

The objectives of this study are 1) To evaluate the effect of a deprescribing-specific interdisciplinary quality circle module on the use of potentially inappropriate medication in nursing-home residents. 2) To determine the effective strategies to reach and implement deprescribing consensus resulting of said quality circle module.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
56
Inclusion Criteria

Nursing homes taking part in the study must have

  • a geriatric of psycho-geriatric mission;
  • been part of their cantonal pharmaceutical assistance program for at least a year.
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionQuality Circle Deprescribing ModuleNursing Homes allocated to the Intervention arm will enact the Quality Circle Deprescribing Module and create a local deprescribing consensus and implementation strategy.
Primary Outcome Measures
NameTimeMethod
Percentage of Potentially Inappropriate Galenic Units12 months

The primary outcome is the percentage, at follow-up, of potentially inappropriate galenic units at follow-up, relative to the total number of galenic units used in the nursing home.

Number of Potentially Inappropriate Defined Daily Doses (DDDs) Per Average Resident and Per Day12 months

Sum of Defined Daily Doses identified as potentially inappropriate (PIM, see protocol for assessement method), divided by the total number of days spent in the NH

Secondary Outcome Measures
NameTimeMethod
Number of Falls Per Average Resident and Per Year12 months

Number of falls per average resident and per year

Number of Potentially Inappropriate DDD to Avoid12 months

Sum of Defined Daily Doses identified as "to avoid" (see protocol for assessement method), divided by the total number of days spent in the NH.

Number of Potentially Inappropriate DDD to Reevaluate12 months

Sum of Defined Daily Doses identified as "to reevaluate" (see protocol for assessement method), divided by the total number of days spent in the NH.

Number of Hospital Days12 months

The number of days spent in the hospital by average resident

Mortality Rate12 months

Number of residents of the nursing home having died during the considered year, divided by the total number of residents having stayed in the nursing home.

Percentage of Residents With at Least One Day of Physical Restraints Use12 months

Number of residents of the nursing home with at least one day of physical restraints use during the considered year, divided by the total number of residents having stayed in the nursing home.

Trial Locations

Locations (1)

Centre de Pharamacie Communautaire

🇨🇭

Lausanne, Vaud, Switzerland

© Copyright 2025. All Rights Reserved by MedPath